- Home
- UTF vs VCYT Comparison
UTF vs VCYT Comparison
Compare UTF & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UTF | VCYT |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | 2004 | 2013 |
Fundamental Metrics
Financial Performance| Metric | UTF | VCYT |
|---|---|---|
| Price | $25.43 | $41.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $44.00 |
| AVG Volume (30 Days) | 244.8K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.76 |
| Revenue Next Year | N/A | $12.35 |
| P/E Ratio | ★ N/A | $61.92 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.42 | $29.46 |
| 52 Week High | $28.11 | $60.91 |
Technical Indicators
Market Signals| Indicator | UTF | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 20.83 | 39.93 |
| Support Level | $25.44 | $40.80 |
| Resistance Level | $27.42 | $42.98 |
| Average True Range (ATR) | 0.29 | 1.76 |
| MACD | -0.12 | 0.14 |
| Stochastic Oscillator | 11.59 | 11.02 |
Price Performance
Historical ComparisonAbout UTF Cohen & Steers Infrastructure Fund Inc
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).